FROBEN

This brand name is authorized in Estonia, Japan, Lithuania, South Africa

Active ingredients

The drug FROBEN contains one active pharmaceutical ingredient (API):

1 Flurbiprofen
UNII 5GRO578KLP - FLURBIPROFEN

Flurbiprofen is a propionic acid derivative NSAID which acts through inhibition of prostaglandin synthesis. In humans flurbiprofen has potent analgesic, antipyretic and anti-inflammatory properties.

Read about Flurbiprofen

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
FROBEN Coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A01AD11 Various A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1669776, 1669787
Country: JP 医薬品医療機器総合機構 Identifier(s): 1149011D1032, 1149011F1076
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1075073
Country: ZA Health Products Regulatory Authority Identifier(s): K/3.1/4, K/3.1/5, Q/3.1/260, Q/3.1/338, V/3.1/90

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.